BU-LAD
![]()  | |
![]()  | |
| Systematic (IUPAC) name | |
|---|---|
| 
 (6aR,9R)-7-butyl-N,N-diethyl-4,6,6a,7,8,9- hexahydroindolo[4,3-fg]quinoline-9-carboxamide  | |
| Clinical data | |
| Routes of administration  | Oral | 
| Legal status | 
  | 
| Pharmacokinetic data | |
| Metabolism | Hepatic | 
| Excretion | Renal | 
| Identifiers | |
| CAS Number | 
96930-87-9  | 
| PubChem | CID 44457782 | 
| ChemSpider | 
21106266  | 
| ChEMBL | 
CHEMBL22520  | 
| Synonyms | BU-LAD, 6-butyl-6-nor-Lysergic acid diethylamide | 
| Chemical data | |
| Formula | C23H31N3O | 
| Molar mass | 365.512 g/mol | 
  | |
  | |
|   | |
BU-LAD, also known as 6-butyl-6-nor-lysergic acid diethylamide, is an analogue of LSD first made by Alexander Shulgin and reported in the book TiHKAL. BU-LAD is a psychedelic drug similar to LSD, but is significantly less potent than LSD,[1] with a dose of 500 micrograms producing only mild effects.
References
- ↑ Hoffman AJ, Nichols DE (September 1985). "Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives". Journal of Medicinal Chemistry 28 (9): 1252–5. doi:10.1021/jm00147a022. PMID 4032428.
 
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

